Lv64
2630 积分 2024-05-16 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
21小时前
已完结
2023 ACR/EULAR antiphospholipid syndrome classification criteria
10天前
已完结
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis
18天前
已完结
The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
18天前
已完结
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis
18天前
已完结
Anti-C1q antibodies in systemic lupus erythematosus
19天前
已完结
The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
19天前
已完结
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis
19天前
已完结
Lupus nephritis
22天前
已完结
Intertwined pathways of complement activation command the pathogenesis of lupus nephritis
22天前
已完结
皖公网安备34019202002308
